Examination of the melatonin hypothesis in women exposed at night to EMF or bright light

Environmental Health Perspectives

Volumn 109, Issue 5, 2001, Pages 501-507

  Graham, Charles ^a   Cook, Mary R ^a   Gerkovich, Mary M ^a   Sastre, Antonio ^a  

^a MIDWEST RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Electromagnetic fields; Estrogen levels; Light at night; Melatonin; Neuroendocrine; Reproductive hormones; Women's health

Indexed keywords

ESTRADIOL; ESTROGEN; HORMONE; MELATONIN;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BRIGHTNESS; CANCER INCIDENCE; CANCER RISK; CIRCADIAN RHYTHM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HYPOTHESIS; INDUSTRIAL AREA; INDUSTRIALIZATION; LABORATORY TEST; LIGHT EXPOSURE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MENSTRUAL CYCLE; NIGHT; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL; TOXICITY TESTING;

EID: 0035325288     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.01109501     Document Type: Article

References (49)

1. Electric power use and breast cancer: A hypothesis
2. Estimates of the worldwide incidence of eighteen major cancers in 1985
3. The Melatonin Hypothesis: Breast Cancer and the Use of Electricity
4. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of the relevant literature
5. Breast cancer and environmental risk factors: Epidemiological and experimental findings
6. The melatonin hypothesis: Electric power and breast cancer
7. Melatonin and the Mammalian Pineal Gland
8. Melatonin in oncology
9. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
10. Stage-dependent depression of melatonin in patients with primary breast cancer
11. 6-Sulphatoxymelatonin production in breast cancer patients
12. The validity of melatonin as an oncostatic agent
13. Exploring the EMF-melatonin connection: A review of the possible effects of 50/60-Hz electric and magnetic fields on melatonin secretion
14. Assessment of Health Effects from Exposure to Power-Line Frequency Electric and Magnetic Fields
15. EMF Science Review Symposium: Breakout Group Reports for Clinical and In Vivo Laboratory Findings
16. NIEHS Report on Health Effects from Exposure to Power-Line Frequency Electric and Magnetic Fields
17. A 50-Hz electromagnetic field impairs sleep
18. Nocturnal melatonin levels in human volunteers exposed to intermittent 60-Hz magnetic fields
19. Human melatonin during continuous magnetic field exposure
20. Multi-night exposure to 60-Hz magnetic fields: Effects on melatonin and its enzymatic metabolite
21. All-night exposure to EMF does not alter urinary melatonin, 6-OHMS, or immune measures, in older men and women
22. Melatonin and 6-OHMS in high-intensity magnetic fields
23. Synopsis topic #5: Quality assurance
24. ELF exposure facility for human testing
25. Test facility for human exposure to AC and DC magnetic fields
26. A replication study of human exposure to 60-Hz fields: Effects on neurobehavioral measures
27. A dose response study of human exposure to 60-Hz electric and magnetic fields
28. Nocturnal exposure to intermittent 60-Hz magnetic fields alters human cardiac rhythm
29. Effects of exposure to a circularly polarized 50-Hz magnetic field on plasma and pineal melatonin levels in rats
30. Prediction of nocturnal plasma melatonin from morning urinary measures
31. Morning urinary assessment of nocturnal melatonin secretion in older women
32. Inhibition of melatonin secretion onset by low levels of illumination
33. The physiology and pharmacology of melatonin in humans
34. Magnetic fields and pineal function in humans: Evaluation of nocturnal acute exposure to ELF magnetic fields on serum melatonin and urinary aMT6s circadian rhythms
35. Melatonin and adrenocorticotropic hormone levels in video display unit workers during work and leisure
36. Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers
37. Relation between residential magnetic fields, light-at-night, and nocturnal urine melatonin levels in women (Report TR-107242)
38. Nocturnal excretion of a urinary melatonin metabolite in electric utility workers
39. Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields
40. Alcohol consumption and urinary concentration of 6-hydroxymelatonin in healthy women
41. Geomagnetic disturbances are associated with reduced nocturnal excretion of a melatonin metabolite in humans
42. Internal electric fields produced by EMF, dosimetry, and endogenous fields
43. Suprachiasmatic Nucleus: The Mind's Clock
44. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection
45. Influence of human model resolution on computed currents induced in organs by 60-Hz magnetic fields
46. Magnetic induction at 60 Hz in the human heart: A comparison between the in situ and isolated scenarios
47. 60-Hz magnetic field exposure effects on the melatonin rhythm and photo period control of reproduction
48. Profound bilateral blindness and the incidence of breast cancer
49. Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields